Skip to main content

Advertisement

Log in

Therapeutic effects of in vivo-differentiated stem cell and Matricaria chamomilla L. Oil in diabetic rabbit

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

The main goal of diabetes therapy is to control blood glucose levels.

Objectives

In this study, the effect of Matricaria chamomilla L. oil as an herbal agent, on therapeutic properties of poly L-lactic acid-based (PLLA) scaffold loaded with differentiated stem cells, is examined in the diabetic rabbit.

Methods

Adipose mesenchymal stem cells (AMSCs) were isolated from male New Zealand White rabbits and after seeding on the PLLA scaffold differentiated in the pancreatic region. In vivo differentiation of AMSCs toward pancreatic progenitor cells was evaluated by quantitative analysis of gene expressions and immunohistochemistry. Then, one normal and five diabetic groups including blank diabetic, scaffold, oil + scaffold, and differentiated cell + scaffold or oil + scaffold were assessed after 21 days of treatment. After the assessment, the diabetic groups were evaluated by clinical parameters and pancreatic histological sections.

Results

It was found that AMSCs were differentiated to insulin-producing cells (IPCs) in the pancreatic environment which then used for implantation. Blood glucose in the oil + scaffold, cell + scaffold, and oil + cell + scaffold groups showed a significant decrease after 21 days. In the above mentioned three groups, insulin secretion was increased significantly. Chamomile oil also caused a significant decrease in High-density lipoprotein (HDL), Low-density lipoprotein (LDL), and total cholesterol levels. According to histological sections results, in cell + scaffold and oil + cell + scaffold groups, β cells were significantly increased compared to blank diabetic group.

Conclusions

Together these data demonstrated chamomile oil along with in vivo-differentiated stem cell is a promising new treatment for diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

AMSCs:

Adipose mesenchymal stem cells

MSCs:

Mesenchymal stem cells

PLLA:

Poly L-lactic acid

IPCs:

Insulin-producing cells

HDL:

High-density lipoprotein

LDL:

Low-density lipoprotein

STZ:

Streptozotocin

FTIR:

Fourier transform infrared

SEM:

Scanning electron microscopy

ROS:

Reactive oxygen species

H&E:

Hematoxylin and Eosin

References

  1. Al-Amin et al., ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiberofficinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006;96:660–6.

  2. Allahverdi et al., A, Abroun S, Jafarian A, Soleimani M, Taghikhani M, Eskandari F. Differentiation of Human Mesenchymal Stem Cells into Insulin-Producing Cells by Using A Lentiviral Vector Carrying PDX1. Cell J. 2015;17:231–42.

  3. Aurich et al., H, Soda M, Kaltvaber P, Vetter M, Weise A, Liehr T, Brulport M, Hengstler JG, Dollinger MM, Fleig WE, Christ B. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut. 2009;58:570–81.

  4. Bakhtina et al., A, Tohfafarosh M, Lichtler A, Arinzeh TL. Characterization and differentiation potential of rabbit mesenchymal stem cells for translational regenerative medicine. In Vitro Cell Dev Biol Anim. 2014;50:251–60.

  5. Bertassoli et al., BM, Neto A, Oliveira FDD, Arroyo MAM, Ferrao JSP, Silva JBD, Pignatari GC, Braga PB. Mesenchymal stem cells: emphasis in adipose tissue. Brazilian Archives of Biology Technology. 2013;56:607–17.

  6. Bianco et al., P, Robey PG. Stem cells in tissue engineering. Nature. 2001;414:118–21.

  7. Cemek et al., M, Kaga S, Şimsek N, Buyukokuroglu ME, Konuk M. Antihyperglycemic and antioxidative potential of Matricariachamomilla L. in streptozotocin-induced diabetic rats. Journal of natural medicines. 2008;62:284–93.

  8. Chao et al., PH, Grayson W, Vunjak-Novakovic G. Engineering cartilage and bone using human mesenchymal stem cells. Journal of Orthopaedic Science. 2007;12:398–404.

  9. Cheng et al., Z, White MF. The AKT ion in non-canonical insulin signaling. Nat Med. 2012;18:351–3.

  10. Corcione et al., A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367–72.

  11. Cui et al., YL, Hou X, Qi AD, Wang XH, Wang H, Cai KY, Yin J, De Yao Y, K. Biomimetic surface modification of poly (L-lactic acid) with gelatin and its effects on articular chondrocytes in vitro. J Biomed Mater Res A. 2003;66:770–8.

  12. Das M (2014) Chamomile: medicinal properties medicinal, biochemical, and agricultural aspects. CRC Press, Boca Raton

    Book  Google Scholar 

  13. Deans et al., RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol. 2000;28:875–84.

  14. Dutta et al., RC, Dutta AK. Cell-interactive 3D-scaffold; advances and applications. Biotechnol Adv. 2009;27:334–9.

  15. Fazili A, Gholami S, Minaie Zangi B, Seyedjafari E et al (2016) In vivo differentiation of Mesenchymal stem cells into insulin producing cells on Electrospun Poly-L-Lactide acid scaffolds coated with Matricaria chamomilla L. Oil. Cell 18:310–21

    Google Scholar 

  16. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold spring harbor protocols. 2008:pdb. prot4986.

  17. Hammes et al., F, Berney M, Wang Y, Vital M, Koster O, Egli T. Flow-cytometric total bacterial cell counts as a descriptive microbiological parameter for drinking water treatment processes. Water Res. 2008;42:269–77.

  18. Helman A, Melton DA. A stem cell approach to cure type 1 diabetes. Cold Spring Harb Perspect Biol, 2020

  19. Jafarian A, Taghikani M, Abroun S, Allahverdi A, Lamei M, Lakpour N, Soleimani M et al (2015) The generation of insulin-producing cells from human Mesenchymal stem cells by MiR-375 and Anti-MiR-9. PLoS One 10:e0128650

    Article  Google Scholar 

  20. Kato et al., A, Minoshima Y, Yamamoto J, Adachi I, Watson AA, Nash RJ. Protective effects of dietary chamomile tea on diabetic complications. J Agric Food Chem. 2008;56:8206–11.

  21. Khan et al., A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26:3215–8.

  22. Le Blanc et al., K, Frassoni F, Ball L, Locatelii F, Roelofc H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringdén O; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.

  23. Lin Y, Zhang F, Lian XF, Peng WQ, Yin CY. Mesenchymal stem cell-derived exosomes improve diabetes mellitus-induced myocardial injury and fibrosis via inhibition of TGF-beta1/Smad2 signaling pathway. Cell Mol Biol (Noisy-le-Grand). 2019;65:123–126.

  24. Ling CQ, Yue XQ, Ling C et al (2014) Three advantages of using traditional Chinese medicine to prevent and treat the tumor. J Integr Med 12:331–5

    Article  Google Scholar 

  25. Mashhadikhan M, Soleimani M, Parivar K, Yaghmaei P et al (2015) ADSCs on PLLA/PCL hybrid nanoscaffold and gelatin modification: cytocompatibility and mechanical properties. Avicenna J Med Biotechnol 7:32–8

    PubMed  PubMed Central  Google Scholar 

  26. Memon B, Abdelalim EM. Stem cell therapy for diabetes: Beta cells versus pancreatic progenitors. Cells. 2020;9.

  27. Padiya et al., R, Chowdhury D, Borkar R, Srinivas R, Pal Bhadra M, Banerjee SK. Garlic attenuates cardiac oxidative stress via activation of PI3K/AKT/Nrf2-Keap1 pathway in fructose-fed diabetic rat. PLoS One. 2014;9:e94228.

  28. Pendleton C, LI Q, Chesler DA, Yuan K, Guerrero-Cazares H, Quinones-Hinojosa A et al (2013) Mesenchymal stem cells derived from adipose tissue vs. bone marrow: in vitro comparison of their tropism towards gliomas. PloS One 8:e58198

    Article  CAS  Google Scholar 

  29. Pradhan S, Farach-Carson MC et al (2010) Mining the extracellular matrix for tissue engineering applications. Regen Med 5:961–70

    Article  CAS  Google Scholar 

  30. Rafraf M, Zemestani M, Asghari-Jafarabadi M. Effectiveness of chamomile tea on glycemic control and serum lipid profile in patients with type 2 diabetes. J Endocrinol Investig. 2015;38:163–70.

    Article  CAS  Google Scholar 

  31. Saeb et al., M, Nazifi S, Mirzaei A. Studies on the effects of Turpentine oil on the serum concentration of Lipids and Lipoproteins of female rabbits. J Shahid Sadoughi Uni Med Sci Health Serv. 2004;3:42–50.

  32. Sheikhpour M, Abolfathi H, Khatami S, Meshkani R, Barghi TS. 2020. The Interaction between gene profile and obesity in type 2 diabetes: A review. Obes Med:100197.

  33. Siu et al., WS, Ko CH, Lam KW, Wat E, Shum WT, Lau CB, Leung PC. 2015. Evaluation of a topical herbal agent for the promotion of bone healing. Evid Based Complement Alternat Med. 2015:905270.

  34. Sun et al., Y, Chen L, Hou XG, Hou WK, Dong JJ, Sun L, Tang KX, Wang B, Song J, Li H, Wang KX. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. (Engl) Chin Med J. 2007;120:771–6.

  35. Sun et al., Y, Chen CS, Fu J. Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment. Annu Rev Biophys. 2012;41:519–42.

  36. Uccelli et al., A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726–36.

  37. Vincent et al., CE, Chinagorom LO. Organ transplantation and its physiological implications. Animal Research International. 2013;10:1752–78.

  38. Vincent CE, Chinagorom LO et al (2013) Organ transplantation and its physiological implications. Anim Res Int 10:1752–78

    Google Scholar 

  39. Yamamoto et al., H, Quinn G, Asari A, Yamanokuchi H, Teratani T, Terada M, Ochiya T. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology. 2003;37:983–93.

  40. Yan et al., SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, inflammation, and RAGE a scaffold for the macrovascular complications of diabetes and beyond. Circ Res. 2003;93:1159–69.

  41. Yeh et al., GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003;26:1277–94.

  42. Zhang Y, Chen W, Feng B, Cao H (2020) The clinical efficacy and safety of stem cell therapy for diabetes Mellitus: A systematic review and meta-analysis. Aging Dis 11:141–53

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soghra Gholami.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fazili, A., Gholami, S., Sheikhpour, M. et al. Therapeutic effects of in vivo-differentiated stem cell and Matricaria chamomilla L. Oil in diabetic rabbit. J Diabetes Metab Disord 19, 453–460 (2020). https://doi.org/10.1007/s40200-020-00530-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-020-00530-3

Keywords

Navigation